Shahbazi Korosh, Solati Kamal, Hasanpour-Dehkordi Ali
PhD Candidate of Health Psychology, Islamic Azad University , Karaj branch, Karaj, Iran .
Associate Professor, Cellular and Molecular Research Center, Shahrekord University of Medical Sciences , Rahmatieh, Shahrekord, Iran .
J Clin Diagn Res. 2016 May;10(5):OC01-4. doi: 10.7860/JCDR/2016/17631.7713. Epub 2016 May 1.
Irritable bowel syndrome (IBS) is one of the most prevalent gastroenterological disorders. IBS is characterized by abdominal pain, cramping, diarrhea, constipation, bloating and flatulence. Complementary therapy is a group of diverse therapeutic and health care systems products that are used in treatment of IBS. Hypnotherapy helps to alleviate the symptoms of a broad range of diseases and conditions. It can be used independently or along with other treatments.
This study was conducted to compare therapeutic effect of hypnotherapy plus standard medical treatment and standard medical treatment alone on quality of life in patients with IBS.
This study is a clinical trial investigating 60 patients who were enrolled according to Rome-III criteria. The sample size was determined per statistical advice, previous studies, and the formula of sample size calculation. The participants were randomly assigned to two groups of hypnotherapy plus standard medical treatment group (n: 30), and standard medical treatment group (30). The study consisted of three steps; prior to treatment, after treatment and six months after the last intervention (follow-up). The instruments of data gathering were a questionnaire of demographic characteristics and standard questionnaire of quality of life for IBS patients (Quality of Life IBS-34). The data were analysed by analysis of co-variance, Levene's test and descriptive statistics in SPSS-18.
There were significant differences between the two groups of study in post-treatment and follow-up stage with regards to quality of life (p<0.05).
Psychological intervention, particularly hypno-therapy, alongside standard medical therapy could contribute to improving quality of life, pain and fatigue, and psychological disorder in IBS patients resistant to treatment. Also, therapeutic costs, hospital stay and days lost from work could be decreased and patients' efficiency could be increased.
肠易激综合征（IBS）是最常见的胃肠疾病之一。肠易激综合征的特征是腹痛、绞痛、腹泻、便秘、腹胀和肠胃胀气。辅助疗法是一组用于治疗肠易激综合征的多种治疗和保健系统产品。催眠疗法有助于减轻多种疾病和病症的症状。它可以单独使用或与其他治疗方法一起使用。
本研究旨在比较催眠疗法加标准药物治疗与单纯标准药物治疗对肠易激综合征患者生活质量的治疗效果。
本研究是一项临床试验，对60例根据罗马III标准入组的患者进行调查。样本量根据统计建议、既往研究以及样本量计算公式确定。参与者被随机分为两组，即催眠疗法加标准药物治疗组（n = 30）和标准药物治疗组（30例）。该研究包括三个阶段：治疗前、治疗后以及最后一次干预后六个月（随访）。数据收集工具为人口统计学特征问卷和肠易激综合征患者生活质量标准问卷（IBS-34生活质量问卷）。数据在SPSS-18中通过协方差分析、Levene检验和描述性统计进行分析。
两组研究在治疗后和随访阶段的生活质量方面存在显著差异（p<0.05）。
心理干预，尤其是催眠疗法，与标准药物治疗相结合，有助于改善难治性肠易激综合征患者的生活质量、疼痛和疲劳以及心理障碍。此外，还可以降低治疗成本、缩短住院时间和减少误工天数，并提高患者的效率。
